Aciron-800 Tablet

Acyclovir 800 mg Tablets — High-Dose Oral Antiviral for Herpes Zoster

Aciron-800 Tablet — Acyclovir 800 mg from Trumac Healthcare PCD Pharma Franchise India

Composition Acyclovir 800 mg
Dosage Form Tablet
Pack Type Alu-Alu Blister
Pack Size 10 x 10 Tablets
MRP ₹ 2490
Therapy Dermatology / Gynaecology — Antiviral (Nucleoside Analogue)
Storage Store below 30 °C in a dry place, protected from light and moisture.

📱 WhatsApp Enquiry📞 Call: +919041677932

About Aciron-800 Tablet

Aciron-800 Tablet is the high-strength oral formulation of Acyclovir 800 mg, used primarily for the treatment of herpes zoster (shingles) and severe varicella in immunocompetent adults. The 800 mg strength achieves the higher plasma levels required to effectively suppress VZV replication, which is less sensitive to acyclovir than HSV.

Like other acyclovir formulations, Aciron-800 relies on viral thymidine kinase for activation, producing acyclovir triphosphate selectively in infected cells. The active metabolite then inhibits viral DNA polymerase and is incorporated into viral DNA, terminating chain elongation and arresting viral replication.

Early initiation of high-dose oral acyclovir within 72 hours of rash onset has been shown to reduce the duration of viral shedding, accelerate lesion healing and lessen acute pain in herpes zoster. Aciron-800 is manufactured by Trumac Healthcare under WHO-GMP conditions and is available for PCD pharma franchise and export.

Indications

  • Herpes zoster (shingles) in adults
  • Varicella (chickenpox) in adolescents and adults
  • Ophthalmic zoster as adjunct therapy
  • Severe or recurrent HSV infections under specialist guidance

Mechanism of Action

Selective phosphorylation by viral thymidine kinase converts Acyclovir to its monophosphate; cellular kinases generate the active triphosphate. Acyclovir triphosphate inhibits viral DNA polymerase and causes obligate chain termination after incorporation into viral DNA.

Dosage & Administration

Adults: 800 mg orally five times daily (approximately every 4 hours, omitting the night dose) for 7–10 days for herpes zoster. For varicella in adolescents: 800 mg four times daily for 5 days. Adjust dose in renal impairment. Begin treatment within 72 hours of rash onset for best results.

Side Effects

Nausea, vomiting, diarrhoea, headache, fatigue, skin rash, photosensitivity. Less commonly: elevated serum creatinine, raised liver enzymes. Rare: neurotoxicity in elderly or renally impaired patients, haemolytic anaemia, thrombocytopenia.

Contraindications & Precautions

Hypersensitivity to acyclovir or valacyclovir. Use with caution in renal impairment, the elderly, dehydration, and in patients receiving nephrotoxic medications. Maintain good oral hydration.

Storage

Store below 30 °C in a dry place, protected from light and moisture.

PCD Pharma Franchise & Third-Party Manufacturing
Aciron-800 Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

What is Aciron-800 Tablet used for?

Aciron-800 Tablet contains Acyclovir 800 mg and is used primarily for the treatment of herpes zoster (shingles) and varicella (chickenpox) in adolescents and adults.

When should Aciron-800 Tablet be started for shingles?

Aciron-800 is most effective when started within 72 hours of rash onset, at a dose of 800 mg five times daily for 7–10 days, as advised by a physician.

Is Aciron-800 available for PCD pharma franchise?

Yes, Trumac Healthcare offers Aciron-800 Tablet on a monopoly-based PCD pharma franchise across India and for export.

How should Aciron-800 Tablet be stored?

Store below 30 °C in a dry place, away from sunlight and moisture. Keep out of reach of children.

Is Aciron-800 WHO-GMP certified?

Yes, Aciron-800 Tablet is manufactured in WHO-GMP and DCGI-compliant facilities under validated quality controls.

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.